1. Cell Cycle/DNA Damage Metabolic Enzyme/Protease
  2. HSP CDK
  3. Hsp90-IN-46

Hsp90-IN-46 是一种 Hsp90 抑制剂。Hsp90-IN-46 对肿瘤细胞株具有广谱抗增殖活性。Hsp90-IN-46 通过减少集落形成、下调增殖标志物 Ki-67 来抑制乳腺癌细胞增殖。Hsp90-IN-46 可抑制 Hsp90 及其 ATP 酶活性,下调下游底物癌蛋白 HER2CDK4,并适度诱导热休克反应。Hsp90-IN-46 在三阴性乳腺癌肿瘤异种移植小鼠模型中具有显著的抗肿瘤活性。Hsp90-IN-46 可用于三阴性乳腺癌、白血病、非小细胞肺癌、结肠癌、卵巢癌、肾癌、前列腺癌等多种癌症的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Hsp90-IN-46

Hsp90-IN-46 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Hsp90-IN-46 is a Hsp90 inhibitor. Hsp90-IN-46 exhibits broad-spectrum antiproliferative activity against tumor cell lines. Hsp90-IN-46 inhibits breast cancer cell proliferation by reducing colony formation and downregulating the proliferation marker Ki-67. Hsp90-IN-46 inhibits Hsp90 and its ATPase activity, downregulates the downstream substrate oncoproteins HER2 and CDK4, and moderately induces the heat shock response. Hsp90-IN-46 shows significant antitumor activity in a mouse model of triple-negative breast cancer tumor xenografts. Hsp90-IN-46 can be used for research on various cancers including triple-negative breast cancer, leukemia, non-small cell lung cancer, colon cancer, ovarian cancer, renal cancer, prostate cancer[1].

IC50 & Target[1]

HSP90

 

体外研究
(In Vitro)

Hsp90-IN-46 (Compound 13b) (0.01-100 μM; 48 h) 在 48 种人类肿瘤细胞系中表现出强效、广谱的抗癌活性,其 GI50 值范围为 2.17 至 9.60 μM,可在 26 种细胞系中实现总生长抑制,且在 5 种浓度下作用 48 h 的测试中,对大多数细胞系的致死性极低[1]
Hsp90-IN-46 (48 h) 对 MCF-7 和 MDA-MB-231 乳腺癌细胞系具有高活性和选择性抑制作用,其 IC50 值分别为 1.33 μM 和 1.95 μM[1]
Hsp90-IN-46 (1-5 μM, 9 days) 抑制 MDA-MB-231 乳腺癌细胞增殖,降低 MCF-7 和 MDA-MB-231 乳腺癌细胞中增殖标志物 Ki67 的表达,下调 Hsp90 底物癌蛋白 HER2 和 CDK4 的表达[1]
Hsp90-IN-46 可在基于体外 AlphaLISA 的分析实验中直接抑制 Hsp90 的活性,其 IC50 为 12.397 μM,可在偶联分光光度法测定中强效抑制 Hsp90 ATP 酶活性,其 IC50 为 0.986 μM[1]
Hsp90-IN-46 (10 μM) 可在 HEK-293 细胞中诱导中度热休克反应,在 10 μM 浓度下使 HspA1A mRNA 表达水平升高 8.7 倍[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay[1]

Cell Line: 48 human tumor cell lines from multiple subpanels (NSCLC, colon, CNS, melanoma, ovarian, renal, prostate, leukemia, breast)
Concentration: 10 μM
Incubation Time: 48 h
Result: Exhibited a mean growth inhibition (GI%) of 78.84% across 48 cell lines.
Showed strong cytotoxicity (GI% 57.74-68.93%) against NSCLC (NCI-H226), colon (HCC-2998, HT29, SW-620), CNS (SF-539), melanoma (M14), ovarian (OVCAR-3, OVCAR-8), renal (A498, RXF 393), and prostate (DU-145) cancer cell lines.
Demonstrated potent cytotoxicity (GI% 70.24-97.44%) against all leukemia cell lines and most NSCLC, melanoma, colon, CNS, ovarian, renal, and breast cancer cell lines.
Induced 56.97% and 4.33% lethality against melanoma SK-MEL-5 and SK-MEL-2 cell lines, respectively.

Cell Cytotoxicity Assay[1]

Cell Line: 60 human tumor cell lines
Concentration: 0.01-100 μM
Incubation Time: 48 h
Result: Demonstrated potent cytotoxicity with GI50 values of 2.17-9.60 μM against 48 cell lines.
Showed lower activity with GI50 values of 10.20-22.70 μM against 12 cell lines.
Induced total growth inhibition (TGI) with values of 6.23-91.00 μM against 26 cell lines (including breast MDA-MB-468, melanoma SK-MEL-5, UACC-62, SK-MEL-2, and ovarian OVCAR-3).
Exhibited minimal toxicity with LC50 >92.5 μM against 57 cell lines, except LC50 values of 27.40-61.30 μM against colon COLO 205 and melanoma SK-MEL-5, UACC-62 cell lines.
Achieved a full-panel GI50 mean graph-midpoint (MG-MID) value of 5.89 μM, with breast cancer MDA-MB-468 as the most sensitive cell line (GI50 = 2.17 μM) and ovarian cancer OVCAR-5 as the least sensitive (GI50 = 22.7 μM).

Cell Cytotoxicity Assay[1]

Cell Line: MCF-7, MDA-MB-231, Caco-2, A549 cancer cell lines; normal human skin fibroblast (HSF) cells
Concentration: Serial concentrations
Incubation Time: 48 h
Result: Displayed IC50 values of 1.33 μM (MCF-7), 1.95 μM (MDA-MB-231), 4.62 μM (Caco-2), 11.89 μM (A549), and 46.96 μM (HSF).
Achieved selectivity index values of 35.31 (MCF-7), 24.08 (MDA-MB-231), 10.16 (Caco-2), and 3.95 (A549).

Cell Proliferation Assay[1]

Cell Line: MDA-MB-231 breast cancer cells
Concentration: 5 μM
Incubation Time: 9 days
Result: Significantly reduced colony formation from 173 colonies per well (control) to 91 colonies per well.
药代动力学
(Parmacokinetics)
Species Dose Route Cmax Tmax T1/2 AUC
Rat[1] 50 mg/kg i.p. 6.74 ± 1.28 μM 1 h 2.98 h 30.68
体内研究
(In Vivo)

Hsp90-IN-46 (13b) (50 mg/kg; i.p.; daily; 6 consecutive days) 在三阴性乳腺癌肿瘤异种移植小鼠模型中具有显著的抗肿瘤活性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c mice (immunocompromised)[1]
Dosage: 50 mg/kg
Administration: i.p.; daily; 6 consecutive days
Result: Reduced MDA-MB-231 xenograft tumor volume and tumor weight by approximately 33%.
Reduced EGFR expression in tumor sections to 0.17-0.92% reaction area.
Maintained stable body weight in treated mice.
分子量

468.30

Formula

C21H18BrN5O3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Hsp90-IN-46
目录号:
HY-181687
需求量: